The monoclonal neutralizing antibody medicine, used to treat coronavirus patients with mild or moderate symptoms, is supplied by Chugai Pharmaceutical Co....
12, Suga emphasized progress on the vaccine rollout and the practical implementation of medication targeting COVID-19 patients with mild symptoms as achievements during his tenure as prime minister....
Regarding Ronapreve, which was authorized for pharmaceutical manufacturing and sales in July, he said," It actually costs 310, 000 yen per
综合
每日新闻-最新
2021-10-14 00:00:00.0